Foghorn Therapeutics, Inc. (FHTX)
6.00
-0.22
(-3.54%)
USD |
NASDAQ |
Aug 28, 16:00
6.00
0.00 (0.00%)
After-Hours: 18:39
Foghorn Therapeutics Gross Profit Margin (Quarterly) : 98.76% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 98.76% |
| March 31, 2026 | 92.72% |
| December 31, 2025 | 91.33% |
| September 30, 2025 | 88.96% |
| June 30, 2025 | 88.09% |
| March 31, 2025 | 86.11% |
| December 31, 2024 | 73.35% |
| September 30, 2024 | 91.03% |
| June 30, 2024 | 88.39% |
| March 31, 2024 | 83.47% |
| December 31, 2023 | 85.23% |
| September 30, 2023 | 95.06% |
| Date | Value |
|---|---|
| June 30, 2023 | 61.31% |
| March 31, 2023 | 61.22% |
| December 31, 2022 | 30.26% |
| September 30, 2022 | 83.39% |
| June 30, 2022 | 56.44% |
| March 31, 2022 | 50.89% |
| December 31, 2021 | -166.5% |
| September 30, 2021 | 0.00% |
| June 30, 2021 | 0.00% |
| March 31, 2021 | 0.00% |
| December 31, 2020 | -124.3% |
| September 30, 2020 | 0.00% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Prime Medicine, Inc. | -54.68% |
| Arrowhead Pharmaceuticals, Inc. | 91.15% |
| Oncolytics Biotech, Inc. | -- |
| Sangamo Therapeutics, Inc. | 39.18% |
| Sarepta Therapeutics, Inc. | 60.18% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | -25.80% |
| Profit Margin (Quarterly) | -44.74% |
| Operating Margin (Quarterly) | -54.78% |
| Return on Net Operating Assets | -238.2% |